[2] Neoadjuvant intravesical chemotherapy to treat extended large non-muscle-invasive bladder cancer
Objective: To report our experience with the use of neoadjuvant intravesical chemotherapy in the treatment of large exophytic bladder tumours. About 75% of bladder cancers are superficial at diagnosis. Sometimes, symptoms are mild or absent, and the tumour can grow unnoticed into a large intra-lumin...
Guardado en:
Autores principales: | Marco Raber, Ismail Hassan, Nashaat Hendawi, Noor Buchholz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0ac3360b28ca4a00b728104860f95059 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Thulium laser enucleation of the prostate (ThuLEP): Results, complications, and risk factors in 139 consecutive cases
por: Marco Raber, et al.
Publicado: (2018) -
[7] Efficacy, complications and tolerability of repeated intravesical onabotulinumtoxinA injections in interstitial cystitis/bladder pain syndrome
por: Riyad Al Mousa, et al.
Publicado: (2018) -
[81] Correlation between intravesical prostatic protrusion and the failure of medical treatment
por: Redouane Rabii, et al.
Publicado: (2018) -
Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
por: Mi Ah Han, et al.
Publicado: (2021) -
[53] Neutrophil-to-lymphocyte ratio in non-muscle-invasive bladder cancer
por: Anés Sempere, et al.
Publicado: (2018)